Prostate-Specific Antigen: Update 2006 - 16/08/11
Doi : 10.1016/j.urology.2005.12.026
Stephen J. Freedland a, ⁎ 
, Alan W. Partin b
, Alan W. Partin b a Department of Surgery, Division of Urology, Duke University School of Medicine, Durham, North Carolina
b Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland
Reprint requests: Stephen J. Freedland, M.D., Duke University Medical Center, Department of Surgery, Box 3850, Durham, NC 27710.Mappa
| Supported by the National Institutes of Health (NIH) Specialized Programs of Research Excellence Grant P50CA58236; Early Detection Research Network/National Cancer Institute/NIH Grant U01-CA86323; the Prostate Cancer Foundation; the Department of Defense Prostate Cancer Research Program, PC030666; and the American Foundation for Urological Disease/American Urological Association Education and Research Scholarship Award. Views and opinions of, and endorsements by the author(s) do not reflect those of the U.S. Army or the Department of Defense. |
© 2006
Elsevier Inc. Tutti i diritti riservati.
Vol 67 - N° 3
P. 458-460 - marzo 2006 Ritorno al numero
Articolo precedente
- Clinical interpretation of prostate biopsy reports
- J. Kellogg Parsons, Alan W. Partin
- Two-trocar laparoscopic varicocelectomy: Cost-reduction surgical technique
- Adel Al-Hunayan, Hamdy Abdulhalim, Elijah O. Kehinde, Ehab El-Barky, Khaleel Al-Awadi, Awni Al-Ateeqi
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?